Do Not Use Cardinal Health Monoject Syringes with Syringe Pumps and PCA Pumps - Letter to Health Care Providers

Today, the U.S. Food and Drug Administration (FDA) issued a Letter to Health Care Providers alerting providers and facilities not to use Cardinal Health Monoject syringes with syringe pumps  or patient-controlled analgesia (PCA) pumps while the FDA further evaluates this issue.

The use of Cardinal Health Monoject syringes with syringe pumps or PCA pumps may result in infusion pump performance issues including overdose, underdose, delay in therapy, and delays in occlusion alarms.

The Letter to Health Care Providers includes important information about Cardinal Health Monoject syringes, including:

1. Recommendations for health care providers and facilities.
2. Background and the FDA’s actions to address the issue.
3. Information on recalls related to the issue.
4. Instructions for reporting problems with a device.

Questions? 

If you have questions about this Letter to Health Care Providers, contact the Division of Industry and Consumer Education (DICE).

Read the Full Alert.